Skip to main content
Fig. 2 | Future Journal of Pharmaceutical Sciences

Fig. 2

From: Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations

Fig. 2

Structures of different venom peptides obtained through X-ray diffraction. Description-1 Example of Tripeptides, Acutolysin A from venom of Agkistrodon acutus. 2 Example of Phospholipase A2, structure of beta2-bungarotoxin showing potassium channel binding by kunitz modules and targeted phospholipase action. 3 Example of Serine proteinase, crystal structure of AaV-SP-II, a glycosylated snake venom serine proteinase from Agkistrodon acutus. 4 Example of Metalloproteinase, crystal structure of VAP2 (macromolecule—catrocollastatin) from Crotalus atrox venom. 5 Example from Waprin family, structure of omwaprin from venom of Oxyuranus microlepidotus. 6 Example of Disintegrin, structure of saxthrombin (macromolecule—thrombin like enzyme defibrase) from venom of Gloydius saxatilis. 7 Example of Crotamine, structure of crotamine (macromolecule—crotamine lle-19) from venom of Brazilian snake Crotalus durissus terrificus. 8 Example of Sarafotoxin, crystal structure of human endothelial ETB receptor in complex with sarafotoxin S6b from venom of Atractaspis engaddensis. 9 Example of Bradykinin potentiating peptides (BPPs), structure of human angiotensin-1 converting enzyme N-domain in complex with BPPb (Bradykinin potentiating peptide b) from venom of Gloydius blomhoffii. 10 Example of three-finger toxins, structure of muscarinic acetylcholine receptor-1 in complex with muscarinic toxin 7 (MT-7) from venom of Dendroaspis angusticeps

Back to article page